Skip to main content

Table 2 Association between AGEs level and diabetic complications

From: The association between advanced glycation end products (AGEs) and ABC (hemoglobin A1C, blood pressure, and low-density lipoprotein cholesterol) control parameters among patients with type 2 diabetes mellitus

Variable

N (%)

AGEs level (%)

P-value

Microvascular complications

 No

174 (59.4)

70.41 ± 11.70

 < 0.001*

 Yes

119 (40.6)

81.48 ± 11.41

Retinopathy

 No

230 (78.5)

71.98 ± 11.46

 < 0.001*

 Yes

63 (21.5)

85.60 ± 11.66

Neuropathy

 No

196 (66.9)

75.20 ± 12.7

0.540

 Yes

96 (32.8)

74.22 ± 13.1

Microalbuminuria

 No

209 (71.3)

74.62 ± 11.5

0.720

 Yes

81 (27.6)

75.30 ± 15.5

CVD

 No

236 (80.5)

75.25 ± 12.6

0.421

 Yes

57 (19.5)

73.48 ± 15.4

  1. AGEs, advanced glycation end-products; CVD, cardiovascular disease
  2. *P < 0.05